PLUR
PLUR
NASDAQ · Biotechnology

Pluri Inc

$3.45
+0.11 (+3.29%)
As of May 9, 2:16 AM ET ·
Financial Highlights (FY 2026)
Revenue
2.05M
Net Income
-34,675,813
Gross Margin
48.9%
Profit Margin
-1,690.3%
Rev Growth
+78.7%
D/E Ratio
250.28
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 48.9% 49.0% 30.3% 30.3%
Operating Margin -1,659.9% -1,493.9% -1.4% -1.5%
Profit Margin -1,690.3% -1,605.8% -1.8% -1.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 2.05M 1.15M 4.21M 5.36M
Gross Profit 1.00M 561.8K 1.28M 1.62M
Operating Income -34,046,512 -17,144,217 -59,264 -77,809
Net Income -34,675,813 -17,461,104 -76,163 -75,826
Gross Margin 48.9% 49.0% 30.3% 30.3%
Operating Margin -1,659.9% -1,493.9% -1.4% -1.5%
Profit Margin -1,690.3% -1,605.8% -1.8% -1.4%
Rev Growth +78.7% +78.7% +17.4% +13.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 16.72M 16.72M 10.60M 10.10M
Total Equity 66.8K 66.8K 12.82M 11.60M
D/E Ratio 250.28 250.28 0.83 0.87
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -32,711,268 -17,386,954 -73,642 -95,229
Free Cash Flow -41,548 -57,067